A survey of implanters of permanent cardiac pacemakers during 1995 was
conducted to determine pacemaker implantation rates and identify pres
ent and changing patterns in pacing practice in South Africa. The five
major pacemaker manufacturers/distributors provided estimates of the
numbers of implanters, implanting institutions, and pacemakers implant
ed in South Africa in 1995. In 1995, pacemaker implantations were perf
ormed by 75 doctors working in 30 hospitals. Since the last survey, wh
ich addressed pacing practices in 1986, the primary permanent pacemake
r implantation rate increased from 16 to 31 devices per million popula
tion per year. There were, however, very large disparities in implant
rates between Asians (219/million/year), whites (150/million/year), co
loureds (16/million/year) and blacks (7/million/year). Over this perio
d the number of implanting centres doubled, although more than half (5
3%) were located in one province. Atrioventricular block remains the m
ain indication for permanent pacing (63% of implants), sinus node diso
rders accounted for 28%,bundle-branch block for 4%, atrioventricular n
ode ablation for tachyarrhythmias for 3%, cardiomyopathy for 1%, and o
ther causes for 1%. Single-chamber units were implanted in 62% of pati
ents, dual-chamber units in 22.5%, and single-pass atrioventricular le
ads (VDD) in 15%. Twenty-four per cent of single-chamber devices had r
ate modulation, and 83% of dual-chamber pacemakers had rate-adaptive f
eatures. Bipolar electrodes were used in 82% of atrial and ventricular
leads; 55% used only bipolar leads, and only 10% used unipolar leads
exclusively. The subclavian introducer technique was used in 80% of le
ad insertions. Major complications were reported in less than 1% of im
plants, and no deaths were documented peri-operatively. The survey has
highlighted the changing trends in pacemaker use, the low pacemaker i
mplantation rate, particularly in blacks, and the centralised nature o
f pacing in the country. While the situation has improved over the yea
rs, access to treatment of proven benefit remains poor.:Furthermore, i
t is proposed that the process of pacemaker audit would be greatly sim
plified by the adoption olf a prospective registry such as that used i
n Europe.